AI assistant
Pulmonx Corp — Director's Dealing 2025
Mar 6, 2025
34428_dirs_2025-03-05_45b9ebd8-2d42-4ec2-89aa-59362e43446a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2025-03-03
Reporting Person: Rose Geoffrey Beran (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-03 | Common Stock | S | 520 | $7.12 | Disposed | 290537 | Direct |
| 2025-03-03 | Common Stock | S | 915 | $7.12 | Disposed | 289622 | Direct |
| 2025-03-03 | Common Stock | S | 2327 | $7.14 | Disposed | 287295 | Direct |
| 2025-03-03 | Common Stock | S | 2017 | $7.12 | Disposed | 285278 | Direct |
| 2025-03-03 | Common Stock | A | 108000 | — | Acquired | 393278 | Direct |
Footnotes
F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
F4: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
F5: Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 3, 2025.